The Inspire Fund is a grant scheme for projects engaging underserved communities on the topic of brain health. Abbey’s Brain ...

In this webinar, we’ll introduce Alzheimer’s Research UK’s Advanced Clinical Fellowship – a unique opportunity designed to support the careers of clinicians committed to dementia research.

For the millions of people affected by dementia and Parkinson’s, better treatments can’t come soon enough. Current options are limited and don’t stop the conditions getting worse. Developing new ...

Blood tests are a promising new tool that could transform how dementia is diagnosed in the UK. These tests could help tackle some of the biggest challenges in the current diagnosis pathway – making it ...

Walk, jog or runJoin our advent challenge, and complete 25 miles throughout December. Whether you walk, jog or run, make every mile count this Christmas and raise funds for vital dementia research.

Last year, presenter and radio host Sian Welby and fiancé Jake were two of the 2,752 people taking part in Walk For A Cure. Here, Sian explains why dementia research is a cause so close to her heart.

Our award-winning campaign lays bare the harsh reality of dementia with our film, Change The Ending. The animation shows, the effect of dementia stealing a prince and princess’s ‘happily ever after’ ...

We have produced several illustrations and infographics of concepts in dementia research, making them more accessible to non-scientific audiences. Please feel free to use them: Sign up to receive our ...

Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact.

Study finds people with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia.

Today the Government pledged £2 million to boost on-going research that aims to diagnose dementia quicker and more accurately than current methods. The new funding will allow researchers to ...

A new study published today in the journal, Lancet Neurology looking at longer term use of the anti-amyloid drug, gantenerumab, may indicate it can delay the onset of Alzheimer’s disease symptoms in ...